The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury.

Kobeissy F, Arja RD, Munoz JC, Shear DA, Gilsdorf J, Zhu J, Yadikar H, Haskins W, Tyndall JA, Wang KK. The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury. Expert Rev Mol Diagn. 2024 Jan-Feb; 24(1-2):67-77.

View in: PubMed

subject areas

Brain Concussion
Diagnostic Tests, Routine
Glial Fibrillary Acidic Protein
Hematologic Tests
Humans
Ubiquitin Thiolesterase

authors with profiles

Firas Kobaissy, Ms, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support